Further functional experiments suggested that Inhibition of RACGAP1 sensitizes triple-negative breast cancer cells to ferroptosis by regulating carnitine palmitoyltransferase 1 A (CPT1A)-dependent FA metabolism. This evidence concerns the gene RACGAP1 and triple-negative breast carcinoma.